share_log

Collplant Biotechnologies' Cash And Cash Equivalents As Of September 30, 2024 Were $15.4M, Expected To Provide Cash Runway Until The End Of 2025

Collplant Biotechnologies' Cash And Cash Equivalents As Of September 30, 2024 Were $15.4M, Expected To Provide Cash Runway Until The End Of 2025

Collplant生物科技截至2024年9月30日的現金及現金等價物爲1540萬美元,預計可提供資金支持直到2025年底。
Benzinga ·  11/27 20:06

Collplant Biotechnologies' Cash And Cash Equivalents As Of September 30, 2024 Were $15.4M, Expected To Provide Cash Runway Until The End Of 2025

Collplant生物科技截至2024年9月30日的現金及現金等價物爲1540萬美元,預計可提供資金支持直到2025年底。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論